Senores Pharmaceuticals Limited, a active public limited company, was established on 26 December 2017 in Ahmedabad, Gujarat, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: L24290GJ2017PLC100263. Registered under ROC Roc Ahmedabad. it is listed. It has an authorized capital of ₹59.00 Cr and a paid-up capital of ₹46.05 Cr.
It upholds a compliant status. In 2024, it reported revenue of ₹40.85 Cr and a net worth of ₹168.12 Cr. Employing 120 professional, Its leadership includes Sanjay Shaileshbhai Majmudar (Director), Ashokbhai Vijaysinh Barot (Director), Swapnil Jatinbhai Shah (Managing Director). Past directors included Sanjay Shaileshbhai Majmudar, Ashokbhai Vijaysinh Barot, Sangeeta Mukur Barot. It holds ₹114.91 Cr open charges and ₹130.75 Cr settled loans. Its latest AGM occurred on 18 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1101 To 1103, 11Th Floor, South Tower, One 42 Opp. Jayantilal Park, Ambali Bopal Road,, Ahmedabad, Gujarat, 380054.
L24290GJ2017PLC100263
100263
26 December 2017
₹59.00 Cr
₹46.05 Cr
Roc Ahmedabad
Listed
Active
Explore comprehensive insights into Senores Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Shaileshbhai Majmudar | Director | 10 Feb 2024 | Current |
| Ashokbhai Vijaysinh Barot | Director | 15 May 2018 | Current |
| Swapnil Jatinbhai Shah | Managing Director | 15 Oct 2021 | Current |
| Naresh Bansilal Shah | Director | 30 Jan 2024 | Current |
| Hemanshu Nitinchandra Pandya | Director | 10 Nov 2023 | Current |
| Chetan Bipinchandra Shah | Whole-Time Director | 10 Nov 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 18 Feb 2024 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2018 | Past |
| Pramod Abcsdd | Director | 11 Oct 2021 | Past |
| Pramod Abcsdd | Director | 11 Oct 2021 | Past |
| Pramod Abcsdd | Director | 01 Jun 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Senores Pharmaceuticals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 133.24% increase. The company also saw a substantial fall in profitability, with a 55.57% decrease in profit. The company's net worth Soared by an impressive increase of 340.17%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Senores Pharmaceuticals had a promoter holding of 71.35% and a public holding of 28.66%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,149,099,080.00
₹1,307,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jun 2025 | Hdfc Bank Limited | ₹4.46 M | Open |
| 02 May 2025 | Hdfc Bank Limited | ₹3.51 M | Open |
| 13 Feb 2025 | Others | ₹45.00 Cr | Open |
| 07 Dec 2024 | Hdfc Bank Limited | ₹1.13 M | Open |
| 19 Jul 2023 | Others | ₹5.00 Cr | Open |
Explore comprehensive loan charge details -
Senores Pharmaceuticals has a workforce of 120 employees as of Feb 10, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Senores Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Senores Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Senores Pharmaceuticals Limited last Annual general meeting of members was held on 18 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited of Rs. 64.00 Cr registered on 31 Dec 2022 with Charge ID 100668335 was modified on 31 Jul 2025. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 0.45 Cr with Charge ID 101113826 was registered on 26 Jun 2025. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 0.35 Cr with Charge ID 101087233 was registered on 02 May 2025. was recorded as a recent event.
The activity Senores Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
A charge registered on 05 Oct 2024 via Charge ID 100984798 with Others was fully satisfied on 17 Mar 2025. was recorded as a recent event.
The CIN of Senores Pharmaceuticals Limited is L24290GJ2017PLC100263.
Senores Pharmaceuticals Limited is headquartered at 1101 To 1103, 11Th Floor, South Tower, One 42 Opp. Jayantilal Park, Ambali Bopal Road,, Ahmedabad, Gujarat, 380054.
Senores Pharmaceuticals Limited was incorporated on 26 December 2017.
The current directors of Senores Pharmaceuticals Limited are
The primary industry of Senores Pharmaceuticals Limited is Manufacturing.
Senores Pharmaceuticals Limited is listed.
The authorized capital of Senores Pharmaceuticals Limited is ₹59.00 Cr, and the paid-up capital is ₹46.05 Cr.
The compliance status of Senores Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX